Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming that the entire holding of the company's shares are in demat form and no requests for rematerialisation or dematerialization were received during the quarter ended September 30, 2026.

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has submitted the voting results and consolidated scrutinizers report of its 11th Annual General Meeting, which was held on September 28, 2026. All resolutions were approved by the members with the requisite majority.

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has informed the Exchange regarding Proceedings of the 11th Annual General Meeting of the Company held on Monday, September 28, 2026.

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has commenced commercial operations at its new IVF Centre/Hub at Gurgaon, Haryana, with effect from September 24, 2026.

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has informed the Exchange about Intimation of Post Dispatch Newspaper Advertisement for the Notice of 11th Annual General Meeting and E-Voting Information.

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has informed the Exchange regarding the dispatch of physical letters to members whose email addresses are not registered with the Company/Registrar & Share Transfer Agent/Depository Participants, containing the web-link and exact navigation path to access the Annual Report for the Financial Year 2025-26.

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 28, 2026.

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has informed the Exchange about Copy of Newspaper Publication regarding Pre-AGM Notice of 11th Annual General Meeting to be on Monday, September 28, 2026, through Video Conferencing (VC)/ Other Audio Visual Means (OAVM).

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, with revenue growth of 9.1% year-on-year to ₹19.4 crores, and reported EBITDA and PAT of ₹2.4 crores and ₹1.8 crores respectively.

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has informed the Exchange about the audio recording of the Earnings Call on the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has published unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has informed the Exchange about Investor Presentation, with certain corrections and additional disclosures incorporated in the Revised Investor Presentation submitted earlier.

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has informed the Exchange about Investor Presentation

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, as required by SEBI regulations, detailing the utilization of proceeds from its Initial Public Offer (IPO). The report indicates no deviation from the objects of the issue, with no range of deviation from the amount of issue proceeds earmarked for objects.

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue growing 9.1% YoY to ₹19.4 Cr, EBITDA declining 52.96% YoY to ₹2.4 Cr, and PAT declining 42.27% YoY to ₹1.8 Cr. The company has also commenced operations at its new IVF Centre/Hub at South Extension, New Delhi, and approved the establishment of 'Gaudium Women Hospital, Lucknow'.

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32, including unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, re-appointment of internal auditor, appointment of secretarial auditor, and statement of deviation(s) or variation(s) regarding the utilization of funds raised through Initial Public Offer (IPO) for the quarter ended June 30, 2026.

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has informed the Exchange regarding Change in Auditors of the company.

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has informed the Exchange regarding Change in Auditors of the company. The Board of Directors has approved the Re-appointment of Ram Rattan & Associates as the Internal Auditor of the Company for the Financial Year 2026-27 and the appointment of M/s. Suresh Nainwal & Company as a Secretarial Auditor of the Company for a term of 5 (five) consecutive years.

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has submitted its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, and has approved the re-appointment of Ram Rattan & Associates as the Internal Auditor, appointment of M/s. Suresh Nainwal & Company as a Secretarial Auditor, and the statement of Deviation(s) or Variation(s) regarding the utilization of funds raised through Initial Public Offer.